Sign in

CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
EIN
813676773
Phone
972-77-331-0156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 6-K Event Report of Foreign Issuer
  3. SC 13D/A Stake Beneficial Ownership Report
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 6-K Event Report of Foreign Issuer
  6. SC 13G Stake Amended Statement of Ownership
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 20-F/A Report Annual and Transition Report of Foreign Private Issuers
  10. 20-F Report Annual and Transition Report of Foreign Private Issuers
  11. 6-K Event Report of Foreign Issuer
  12. 6-K Event Report of Foreign Issuer
  13. SC 13D/A Stake Beneficial Ownership Report
  14. SC 13D Stake Beneficial Ownership Report
  15. 6-K Event Report of Foreign Issuer
  16. 424B4 Offering Prospectus
  17. 6-K Event Report of Foreign Issuer
  18. CT ORDER Other Confidential Order
  19. EFFECT Other Notice of Effectiveness
  20. CERT Other Certification

Page 16 of 19 · 368 filings